Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) has achieved its highest national market share of 3.2% in July 2024, positioning it as the 9th largest licensed cannabis producer in Canada. The company reported an approximate 11.8% market share in Quebec, marking its highest monthly national retail sales to date. Cannara operates two mega facilities in Quebec, spanning over 1,650,000 sq. ft., and focuses on producing premium-grade cannabis and derivative products at affordable prices.
The company will host a live investor webcast on August 20, 2024, at 2:00 PM ET, where CFO Nicholas Sosiak will present Q3 2024 financial results and discuss future growth strategies. Investors can pre-register for the webcast and participate in a Q&A session.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) ha raggiunto il suo massimo quota di mercato nazionale del 3,2% a luglio 2024, posizionandosi come il nono produttore di cannabis autorizzato più grande in Canada. L'azienda ha registrato una quota di mercato approssimativa dell'11,8% in Quebec, segnando le sue vendite al dettaglio nazionali mensili più alte fino ad oggi. Cannara gestisce due mega strutture in Quebec, che coprono oltre 1.650.000 piedi quadrati, e si concentra sulla produzione di cannabis di alta qualità e prodotti derivati a prezzi accessibili.
L'azienda ospiterà un webcast dal vivo per gli investitori il 20 agosto 2024, alle 14:00 ET, dove il CFO Nicholas Sosiak presenterà i risultati finanziari del terzo trimestre 2024 e discuterà le strategie di crescita future. Gli investitori possono preregistrarsi per il webcast e partecipare a una sessione di domande e risposte.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) ha alcanzado su máxima participación de mercado nacional del 3,2% en julio de 2024, posicionándose como el noveno productor de cannabis con licencia más grande en Canadá. La compañía reportó una participación de mercado aproximada del 11,8% en Quebec, marcando sus más altas ventas minoristas nacionales mensuales hasta la fecha. Cannara opera dos mega instalaciones en Quebec, abarcando más de 1.650.000 pies cuadrados, y se enfoca en producir cannabis de primera calidad y productos derivados a precios accesibles.
La empresa llevará a cabo un webcast en vivo para inversores el 20 de agosto de 2024, a las 2:00 PM ET, donde el CFO Nicholas Sosiak presentará los resultados financieros del tercer trimestre de 2024 y discutirá las estrategias de crecimiento futuro. Los inversores pueden preinscribirse para el webcast y participar en una sesión de preguntas y respuestas.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF)는 2024년 7월에 3.2%의 가장 높은 국가 시장 점유율을 달성했습니다, 이를 통해 캐나다에서 아홉 번째로 큰 면허를 가진 대마초 생산업체로 자리 잡았습니다. 이 회사는 퀘벡에서 약 11.8%의 시장 점유율을 보고했습니다, 이는 지금까지의 월간 국가 소매 판매 기록을 최고로 갱신한 것입니다. Cannara는 퀘벡에 1,650,000 평방피트 규모의 두 개의 대형 시설을 운영하며, 높은 품질의 대마초와 파생 제품을 합리적인 가격에 생산하는 데 중점을 두고 있습니다.
회사는 2024년 8월 20일 오후 2시에 투자자 라이브 웹캐스트를 개최할 예정이며, CFO인 Nicholas Sosiak이 2024년 3분기 재무 결과를 발표하고 향후 성장 전략에 대해 논의합니다. 투자자들은 웹캐스트에 사전 등록하고 Q&A 세션에 참여할 수 있습니다.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) a atteint sa plus haute part de marché nationale de 3,2 % en juillet 2024, se plaçant ainsi comme le neuvième plus grand producteur de cannabis agréé au Canada. La société a rapporté une part de marché d'environ 11,8 % au Québec, marquant ses plus hautes ventes au détail nationales mensuelles à ce jour. Cannara exploite deux mégas installations au Québec, s'étendant sur plus de 1 650 000 pieds carrés, et se concentre sur la production de cannabis de qualité supérieure et de produits dérivés à des prix abordables.
La société animera un webinaire en direct pour investisseurs le 20 août 2024 à 14h00 ET, où le directeur financier Nicholas Sosiak présentera les résultats financiers du troisième trimestre 2024 et discutera des stratégies de croissance futures. Les investisseurs peuvent s'inscrire à l'avance pour le webinaire et participer à une séance de questions-réponses.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) hat im Juli 2024 einen Höchststand von 3,2% im nationalen Marktanteil erreicht, wodurch das Unternehmen als der neuntgrößte lizenzierte Cannabisproduzent in Kanada positioniert ist. Das Unternehmen berichtete von einem ungefähr 11,8% Marktanteil in Quebec, was die höchsten monatlichen nationalen Einzelhandelsverkäufe bis heute markiert. Cannara betreibt zwei Mega-Einrichtungen in Quebec mit einer Fläche von über 1.650.000 Quadratfuß und konzentriert sich auf die Produktion von Premium-Cannabis und Derivaten zu erschwinglichen Preisen.
Das Unternehmen veranstaltet am 20. August 2024 um 14:00 Uhr ET ein Live-Webcast für Investoren, in dem CFO Nicholas Sosiak die finanziellen Ergebnisse des dritten Quartals 2024 präsentieren und zukünftige Wachstumsstrategien erörtern wird. Investoren können sich im Voraus für das Webcast registrieren und an einer Q&A-Sitzung teilnehmen.
- Achieved highest national market share of 3.2% in July 2024
- Ranked as 9th largest licensed producer in Canada by market share
- Reached approximately 11.8% market share in Quebec
- Recorded highest monthly national retail sales in company history
- None.
MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that the Company has achieved its highest national market share of
“We are thrilled to report that July 2024 marks a significant milestone for Cannara, with our highest monthly national retail sales in the Company's history, including an approximate
Cannara will host a live investor webcast on Tuesday, August 20, 2024, at 2:00 PM ET. Nicholas Sosiak, CFO, will lead the presentation, covering key aspects of the business and delivering a detailed update on Q3 2024 financial results. Following the presentation, investors will have the opportunity to participate in an interactive Q&A session.
Date & Time: August 20, 2024, at 2:00 PM ET
Webcast Link: https://us02web.zoom.us/webinar/register/WN_1SEpVsglTTCKYq38DlMKBg
To listen to the webcast or participate in the live Q&A, please pre-register using the link provided above.
For those unable to attend the live event, an archived version of the webcast and presentation will be available on the Company's investor relations website at https://investors.cannara.ca.
Contact:
Nicholas Sosiak, CPA, CA
Chief Financial Officer
nicholas.sosiak@cannara.ca
Zohar Krivorot
President & Chief Executive Officer
zohar.krivorot@cannara.ca
About Cannara Biotech Inc.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit https://www.cannara.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding “Forward-Looking” Information
This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
1 Based on estimated sales data provided by HiFyre Retail Analytics, Licensed Producer Sales Nationally, for the period of July 2024.
FAQ
What was Cannara Biotech's national market share in July 2024?
What is Cannara Biotech's market share in Quebec as of July 2024?
When is Cannara Biotech (LOVFF) hosting its investor webcast for Q3 2024 results?
What is Cannara Biotech's ranking among licensed cannabis producers in Canada?
